Jenny Han

Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes

Ralph A. DeFronzo, Robert E. Ratner, Jenny Han et al. · Diabetes Care · 2005 · 1.5K citations

Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes

John B. Buse, Robert R. Henry, Jenny Han et al. · Diabetes Care · 2004 · 1.3K citations · Full text

Effect of Intravenous Infusion of Exenatide (Synthetic Exendin-4) on Glucose-Dependent Insulin Secretion and Counterregulation During Hypoglycemia

Kristine B. Degn, Birgitte Brock, Claus Bogh Juhl et al. · Diabetes · 2004 · 253 citations · Full text

Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial

Michaëla Diamant, Luc Van Gaal, Bruno Guerci et al. · The Lancet Diabetes & Endocrinology · 2014 · 152 citations

Diabetes Management, Insulin Management, Diabetes +9

A randomized, open-label, crossover study examiningthe effect of injection site on bioavailability of exenatide (synthetic exendin-4)

Federico Calara, Kristin Taylor, Jenny Han et al. · Clinical Therapeutics · 2005 · 94 citations

Injection Site, Pharmaceutical Science, Excipients +6